PPD CorEvitas Rheumatology Registries
Our independent patient registries track information about the health status of patients and the care they receive, bringing together large regulatory-grade proprietary data sets to analyze patterns in treatment and outcomes, informing best practices and treatment decisions.
Developed and maintained under the guidance of scientific advisors who are preeminent experts in their fields, these registries feature exceptional data completeness and scientific rigor.
Now enrolling qualified sites for our rheumatology registries!
CorEvitas Japan Rheumatoid Arthritis Registry
Obtain data and evidence on the comparative effectiveness and safety of approved therapies for rheumatoid arthritis (RA) in a cohort of Japanese patients treated by rheumatologists. The PPD™ CorEvitas™ Japan RA Registry is a prospective, multi-site, observational, real-world study that collects information on patients with RA.
Our extensive Japan RA Registry comprises
Study visits
Patients
Rheumatologists
Examples of the robust outcome measures collected in the CorEvitas Japan Rheumatoid Arthritis Registry
Calculated outcomes
- Disease Activity Score (DAS28)
- Clinical Disease Activity Index (CDAI)
- Simple Disease Activity Index (SDAI)
Patient-reported outcomes
- Euro-QoL Group EQ-5D-3L
- Japanese version of the Health Assessment Questionnaire (J-HAQ)
- Patient Global Assessment
- Pain Visual Analogue Scale
- Morning Stiffness Visual Analogue Scale
- Fatigue Visual Analogue Scale
- Work Productivity and Activity Impairment (WPAI)
- Health care resource utilization
Make these data work for you.
Join our Registry Investigator Network to improve patient health outcomes
CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Gain a deeper understanding of the impact of psoriatic arthritis (PsA) and spondyloarthritis on patients’ response to therapy and quality of life, as well as clinician- and patient-reported outcomes detailing persistence patterns and unmet needs associated with the disease and its treatment. The CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry features regulatory-grade real-world data and evidence that can be used to inform research and decision-making.
Our PsA/Spondyloarthritis Registry comprises
Study visits
Patients
Rheumatologists
Examples of the robust outcome measures collected in the CorEvitas PsA/Spondyloarthritis Registry
Clinician-reported outcomes
- SPARCC/Leeds Enthesitis Index
- Dactylitis
Calculated measures
- American College of Rheumatology Response Criteria (ACR)
- Disease Activity Score (DAS)
- Clinical Disease Activity Index (CDAI)
- Simple Disease Activity Index (SDAI)
- Psoriatic Arthritis Response Criteria (PsARC)
- Composite Psoriatic Disease Activity Index (CPDAI)
- Assessment of Spondyloarthritis International Society (ASAS) scores
- Ankylosing Spondylitis Disease Activity Score (ASDAS)
Patient-reported outcomes
- Work Productivity and Activity Impairment (WPAI)
- Euro-QoL Group EQ-5D-3L
- Health Assessment Questionnaire for the Spondyloarthropathies (HAQ-S)
- Pain Visual Analogue Scale
- Stiffness Visual Analogue Scale
- Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)
- Bath Ankylosing Spondylitis Functional Index (BASFI)
- Assessment of Spondyloarthritis International Society Health Index (ASAS HI)
Make these data work for you.
Join our Registry Investigator Network to improve patient health outcomes
CorEvitas Rheumatoid Arthritis (RA) Registry
Gain insight and fill data voids with robust, longitudinal real-world data from the most extensive rheumatoid arthritis real-world prospective cohort study in the world. Explore regulatory-grade data examining the long-term real-world effectiveness, safety and treatment patterns of approved therapies, including clinician- and patient-reported outcomes. Leverage more than 20 years of deep clinical data and evidence to inform your research and decision-making.
Explore data from the world’s largest RA Registry
Study visits
Patients
Rheumatologists
Examples of the robust outcome measures collected in the CorEvitas RA Registry
Clinician-reported outcomes
- Disease Activity Score (DAS28)
- Clinical Disease Activity Index (CDAI)
- Simple Disease Activity Index (SDAI)
Patient-reported outcomes
- Euro-QoL Group EQ-5D-3L
- Health Assessment Questionnaire (HAQ)
- Patient Global Assessment
- Pain Visual Analogue Scale
- Morning Stiffness Visual Analogue Scale
- Fatigue Visual Analogue Scale
Make these data work for you.
Join our Registry Investigator Network to improve patient health outcomes
CorEvitas Systemic Lupus Erythematosus (SLE) Registry
Established in 2025
Gain insight from this prospective registry, leveraging detailed patient-level data on SLE to enable assessment of the natural history of the disease, treatment patterns, real-world safety of medications used, disease burden and unmet needs in patients living with SLE. Granular, longitudinal outcome measures are collected during regular visits, including clinician-reported SLE outcomes, biologics and lab measures, and patient-reported outcomes assessing symptom impact and quality of life.
Examples of the robust outcome measures collected in the CorEvitas SLE Registry
Clinician-reported outcomes
- 28 Joint Count
- Hybrid SELENA SLEDAI
- SELENA-SLEDAI Flare Index
- SLICC
Patient-reported outcomes
- Healthcare resource utilization (outpatient & ER visits, hospitalizations)
- Pain Numeric Rating Scale (NRS)
- Fatigue NRS
- Patient Global NRS
- European Quality of Life 5 Dimensions 5 Level Version (EQ-5D-5L)
- Work Productivity and Activity Impairments (WPAI)
Make these data work for you.
Join our Registry Investigator Network to improve patient health outcomes